Roche gains FDA approval for Tecentriqs expanded label, marking the first combo maintenance therapy for extensive-stage small cell lung cancer.

Older adults especially benefit from this therapeutic practice, say the authors.

The new Centers for Disease Control and Prevention recommendation maintains access for the shot through health insurance. The ...

A Yale School of Medicine-led research group, working with six US health systems, reports an association between a single ...